Cargando…
Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206255/ https://www.ncbi.nlm.nih.gov/pubmed/34131107 http://dx.doi.org/10.1038/s41420-020-00388-7 |
_version_ | 1783708603178287104 |
---|---|
author | Arulananda, Surein O’Brien, Megan Evangelista, Marco Harris, Tiffany J. Steinohrt, Nikita S. Jenkins, Laura J. Walkiewicz, Marzena O’Donoghue, Robert J. J. Poh, Ashleigh R. Thapa, Bibhusal Williams, David S. Leong, Trishe Mariadason, John M. Li, Xia Cebon, Jonathan Lee, Erinna F. John, Thomas Fairlie, W. Douglas |
author_facet | Arulananda, Surein O’Brien, Megan Evangelista, Marco Harris, Tiffany J. Steinohrt, Nikita S. Jenkins, Laura J. Walkiewicz, Marzena O’Donoghue, Robert J. J. Poh, Ashleigh R. Thapa, Bibhusal Williams, David S. Leong, Trishe Mariadason, John M. Li, Xia Cebon, Jonathan Lee, Erinna F. John, Thomas Fairlie, W. Douglas |
author_sort | Arulananda, Surein |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8206255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82062552021-07-01 Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma Arulananda, Surein O’Brien, Megan Evangelista, Marco Harris, Tiffany J. Steinohrt, Nikita S. Jenkins, Laura J. Walkiewicz, Marzena O’Donoghue, Robert J. J. Poh, Ashleigh R. Thapa, Bibhusal Williams, David S. Leong, Trishe Mariadason, John M. Li, Xia Cebon, Jonathan Lee, Erinna F. John, Thomas Fairlie, W. Douglas Cell Death Discov Correction Nature Publishing Group UK 2021-06-15 /pmc/articles/PMC8206255/ /pubmed/34131107 http://dx.doi.org/10.1038/s41420-020-00388-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Arulananda, Surein O’Brien, Megan Evangelista, Marco Harris, Tiffany J. Steinohrt, Nikita S. Jenkins, Laura J. Walkiewicz, Marzena O’Donoghue, Robert J. J. Poh, Ashleigh R. Thapa, Bibhusal Williams, David S. Leong, Trishe Mariadason, John M. Li, Xia Cebon, Jonathan Lee, Erinna F. John, Thomas Fairlie, W. Douglas Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title_full | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title_fullStr | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title_full_unstemmed | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title_short | Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma |
title_sort | correction: bcl-xl is an actionable target for treatment of malignant pleural mesothelioma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206255/ https://www.ncbi.nlm.nih.gov/pubmed/34131107 http://dx.doi.org/10.1038/s41420-020-00388-7 |
work_keys_str_mv | AT arulanandasurein correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT obrienmegan correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT evangelistamarco correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT harristiffanyj correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT steinohrtnikitas correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT jenkinslauraj correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT walkiewiczmarzena correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT odonoghuerobertjj correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT pohashleighr correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT thapabibhusal correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT williamsdavids correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT leongtrishe correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT mariadasonjohnm correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT lixia correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT cebonjonathan correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT leeerinnaf correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT johnthomas correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma AT fairliewdouglas correctionbclxlisanactionabletargetfortreatmentofmalignantpleuralmesothelioma |